In 2024, Eesti Farmakoloogia Selts had revenue of 234 EUR. Beneficial owners: Alar Irs, Külli Jaako, Malle Kuum.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 234 € -57.2% | 547 € -56.0% | 1,2k € -93.8% |
Profit | - | - | - |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - | - | - |
Employees | - | - | - |
Overall rating | C+64/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 35/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | - | |||
| - | Board member | - | |||
| - | Board member | - |
Eesti Farmakoloogia Selts is located at Tartu maakond, Tartu linn, Tartu linn, Ülikooli tn 18, 51014.
The beneficial owners of Eesti Farmakoloogia Selts are Alar Irs, Külli Jaako and Malle Kuum. View ownership details →
No, Eesti Farmakoloogia Selts does not have an active VAT number and is not registered as a VAT payer.
Eesti Farmakoloogia Selts was founded on February 25, 1999. The company has been operating for 27 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 27 years | 59 - 63 | 79% | |
Net revenue | 234,00 € | 272 - 276 | 4% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Estonian business register.
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Alar Irs | EE | - | |
| Külli Jaako | EE | - | |
| Malle Kuum | EE | - |